Literature DB >> 8103946

Combined therapy of coarctation and coronary heart disease in an adult.

D Fernández de Caleya1, J Duarte, A Eguren, N Torrente, A Lozano, J Nuche.   

Abstract

The association of aortic coarctation and ischaemic cardiopathy is rare. We present a case of such an association in a 58-year-old patient with established spinal-cord damage and describe a one-stage surgical approach for the correction of both pathologies. Coarctation is solved by means of a supracoeliac to thoracic aortic bypass, and then coronary bypass grafting is performed under CPB. In this case grafts were carried out using the left internal mammary artery (IMA) even though it was hypertrophied. There were no postoperative complications and at 10 months the patient was asymptomatic.

Entities:  

Mesh:

Year:  1993        PMID: 8103946     DOI: 10.1055/s-2007-1013838

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

1.  Asymptomatic severe aortic coarctation in an 80-year-old man.

Authors:  Servet Cevik; Cemil Izgi; Cihan Cevik
Journal:  Tex Heart Inst J       Date:  2004

2.  Correction of coarctation of the aorta with simultaneous off-pump myocardial revascularization.

Authors:  Fernando Moraes; Diana Lamprea; João Wanderley; Carlos R Moraes
Journal:  Tex Heart Inst J       Date:  2003

3.  The unusual hypertensive patient.

Authors:  Saad Al Bugami; Mansour Al Motairi; Ahmed Al Zahrani; Atif Al Zahrani
Journal:  J Saudi Heart Assoc       Date:  2011-10-25

4.  Aortic Coarctation Effect on Atherosclerosis of the Left Internal Mammary Artery: A Case Presentation and Literature Review.

Authors:  Hassane Abdallah; Ahmed Ibrahim; Mohamad Ibrahem Abdelhamed
Journal:  Cureus       Date:  2021-12-26

5.  Simultaneously surgical management of adult complex coarctation of aorta concomitant with intracardiac abnormality.

Authors:  Luyao Ma; Qun Gu; Buqing Ni; Haoliang Sun; Xiangxiang Zhen; Shijiang Zhang; Yongfeng Shao
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.